Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer side effects.

British scientists have hailed the US approval of a new drug for schizophrenia, saying it “has the potential to change the lives of millions of people”. The “major advance” in treatment offers a completely new drug approach to treating the condition,

Cobenfy doesn’t have the same severe side effects as older schizophrenia medications — like weight gain, involuntary muscle movement, and sedation — that can cause patients to discontinue treatment.